Inventor · disambiguated record
Frederic Tremblay
Also filed as: TREMBLAY FREDERIC
7 granted patents·9 pending applications·12 citations·filing 2008–2025
78Inventor score
Top patents by PatentIndex Score
16 records- 0195US11180757B117β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Nov 23, 2021·3 cites·30 claims
- 0294US11149276B2Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Oct 19, 2021·4 cites·30 claims
- 0393US11926832B2Ketohexokinase (KHK) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Mar 12, 2024·4 cites·30 claims
- 0484US11162103B2Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Nov 2, 2021·1 cites·23 claims
- 0581US12404508B2Ketohexokinase (KHK) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted Sep 2, 2025·0 cites·29 claims
- 0677US2025188456A1High mobility group box-1 (hmgb1) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0776US2025333737A117ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOFREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0870US12359201B217ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jul 15, 2025·0 cites·39 claims
- 0966US12480125B2Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Nov 25, 2025·0 cites·20 claims
- 1061US2023416748A1KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1160US2020308588A1High mobility group box-1 (hmgb1) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1256US2023287432A1G protein-coupled receptor 146 (gpr146) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1356US2023183707A1Compositions and methods for inhibiting marc1 gene expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1452US2023190785A1Compositions and methods for silencing dnajc15 gene expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1547US2008241129A1Adipocyte secreted protein ccdc80 is a potent stimulator of bone formationWYETH CORP·Filed 2008·Application pending·0 cites
- 1645US2008221057A1Secreted protein ccdc80 regulates adipocyte differentiationWYETH CORP·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederic Tremblay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →